June 2017

According to a RAND study in Health Affairs, MACRA will slow the rate of growth for the program's spending on physician services,…

The 21st Century Cures Act (“Act”), which provides substantial funding for medical research, seeks to alleviate the regulatory…

The City of Chicago recently released a draft of the disclosure log pharmaceutical representatives will be expected to use to keep…

Lawmakers across America have started to take a variety of matters into their own hands, the most recent of which is Maintenance…

Allergan has been hit with hefty fines over the past several months. This article outlines Allergan's alleged wrongdoing, and the…

The Maine Legislature recently passed LD 911, An Act to Prohibit Certain Gifts to Health Care Practitioners, through the unanimous…

On Tuesday, June 27, 2017, California Senate Bill 790 will be heard in the Assembly Committee on Health, with limited testimony…

In constructively bringing an end to a False Claims Act (“FCA”) whistleblower suit alleging Genentech, Inc. (“Genentech”) of…

For the past three years, Amgen has faithfully released an annual “Trends in Biosimilars Report.” This year’s report highlights…

Lately pharmaceutical marketing has been under increasing attack at both state and federal governmental levels. Now Chicago has…